speb/financial-data huggingface dataset:
BCT.TO balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 1678136.00
BCT.TO balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 71854.00
BCT.TO income_statement (quarterly, 2026-04-30) — Total Operating Income As Reported: -7620794.00
BCT.TO income_statement (quarterly, 2026-04-30) — Total Unusual Items: 258453.00
BCT.TO income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: 258453.00
BCT.TO balance_sheet (quarterly, 2026-04-30) — Working Capital: 21802678.00
BCTX income_statement (annual, 2021-07-31) — +Operating Expense: 6972344.00
BCTX income_statement (annual, 2021-07-31) — +Total Revenue: 0.00
BCTX balance_sheet (annual, 2021-07-31) — Accounts Payable: 214116.00
BCTX balance_sheet (annual, 2021-07-31) — Accounts Receivable: 12574.00
BCTX balance_sheet (annual, 2021-07-31) — Additional Paid In Capital: 2178130.00
BCTX income_statement (annual, 2021-07-31) — Amortization: 15254.00
BCTX income_statement (annual, 2021-07-31) — Amortization Of Intangibles Income Statement: 15254.00
BCTX cash_flow (annual, 2021-07-31) — Beginning Cash Position: 21249.00
BCTX balance_sheet (annual, 2021-07-31) — Capital Stock: 54774172.00
BCTX balance_sheet (annual, 2021-07-31) — Cash And Cash Equivalents: 57268685.00
BCTX balance_sheet (annual, 2021-07-31) — Cash Cash Equivalents And Short Term Investments: 57268685.00
BCTX balance_sheet (annual, 2021-07-31) — Cash Financial: 57268685.00
BCTX cash_flow (annual, 2021-07-31) — Cash Flow From Continuing Financing Activities: 64997624.00
BCTX cash_flow (annual, 2021-07-31) — Cash Flow From Continuing Investing Activities: 0.00
BCTX cash_flow (annual, 2021-07-31) — Cash Flow From Continuing Operating Activities: -7750188.00
BCTX cash_flow (annual, 2021-07-31) — Change In Account Payable: -1405664.00
BCTX cash_flow (annual, 2021-07-31) — Change In Accrued Expense: -785399.00
BCTX cash_flow (annual, 2021-07-31) — Change In Payable: -1405664.00
BCTX cash_flow (annual, 2021-07-31) — Change In Payables And Accrued Expense: -2191063.00
BCTX cash_flow (annual, 2021-07-31) — Change In Prepaid Assets: -100984.00
BCTX cash_flow (annual, 2021-07-31) — Change In Receivables: 9941.00
BCTX cash_flow (annual, 2021-07-31) — Change In Working Capital: -2282106.00
BCTX cash_flow (annual, 2021-07-31) — Changes In Cash: 57247436.00
BCTX balance_sheet (annual, 2021-07-31) — Common Stock: 54774172.00
BCTX balance_sheet (annual, 2021-07-31) — Common Stock Equity: 27671721.00
BCTX cash_flow (annual, 2021-07-31) — Common Stock Issuance: 51622337.00
BCTX cash_flow (annual, 2021-07-31) — Common Stock Payments: 0.00
BCTX balance_sheet (annual, 2021-07-31) — Current Accrued Expenses: 261712.00
BCTX balance_sheet (annual, 2021-07-31) — Current Assets: 57798150.00
BCTX balance_sheet (annual, 2021-07-31) — Current Liabilities: 556795.00
BCTX cash_flow (annual, 2021-07-31) — Depreciation Amortization Depletion: 15256.00
BCTX income_statement (annual, 2021-07-31) — Depreciation Amortization Depletion Income Statement: 15254.00
BCTX cash_flow (annual, 2021-07-31) — Depreciation And Amortization: 15256.00
BCTX income_statement (annual, 2021-07-31) — Depreciation And Amortization In Income Statement: 15254.00
BCTX income_statement (annual, 2021-07-31) — Depreciation Income Statement: 15254.00
BCTX balance_sheet (annual, 2021-07-31) — Derivative Product Liabilities: 29789260.00
BCTX income_statement (annual, 2021-07-31) — Diluted NI Availto Com Stockholders: -13816200.00
BCTX income_statement (annual, 2021-07-31) — EBIT: -13737646.00
BCTX income_statement (annual, 2021-07-31) — EBITDA: -13722390.00
BCTX cash_flow (annual, 2021-07-31) — Effect Of Exchange Rate Changes: 0.00
BCTX cash_flow (annual, 2021-07-31) — End Cash Position: 57268685.00
BCTX cash_flow (annual, 2021-07-31) — Financing Cash Flow: 64997624.00
BCTX cash_flow (annual, 2021-07-31) — Free Cash Flow: -7750188.00
BCTX cash_flow (annual, 2021-07-31) — Gain Loss On Investment Securities: 4448957.00
BCTX income_statement (annual, 2021-07-31) — Gain On Sale Of Security: -6626748.00
BCTX balance_sheet (annual, 2021-07-31) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTX income_statement (annual, 2021-07-31) — General And Administrative Expense: 4955136.00
BCTX balance_sheet (annual, 2021-07-31) — Goodwill And Other Intangible Assets: 245610.00
BCTX income_statement (annual, 2021-07-31) — Insurance And Claims: 318034.00
BCTX income_statement (annual, 2021-07-31) — Interest Expense: 78554.00
BCTX income_statement (annual, 2021-07-31) — Interest Expense Non Operating: 78554.00
BCTX income_statement (annual, 2021-07-31) — Interest Income: 3149.00
BCTX income_statement (annual, 2021-07-31) — Interest Income Non Operating: 3149.00
BCTX balance_sheet (annual, 2021-07-31) — Invested Capital: 27697707.00
BCTX cash_flow (annual, 2021-07-31) — Investing Cash Flow: 0.00
BCTX balance_sheet (annual, 2021-07-31) — Investments And Advances: 2.00
BCTX cash_flow (annual, 2021-07-31) — Issuance Of Capital Stock: 51622337.00
BCTX cash_flow (annual, 2021-07-31) — Issuance Of Debt: 215710.00
BCTX balance_sheet (annual, 2021-07-31) — Long Term Debt: 25986.00
BCTX balance_sheet (annual, 2021-07-31) — Long Term Debt And Capital Lease Obligation: 25986.00
BCTX cash_flow (annual, 2021-07-31) — Long Term Debt Issuance: 215710.00
BCTX cash_flow (annual, 2021-07-31) — Long Term Debt Payments: -309645.00
BCTX cash_flow (annual, 2021-07-31) — Net Common Stock Issuance: 51622337.00
BCTX cash_flow (annual, 2021-07-31) — Net Foreign Currency Exchange Gain Loss: 0.00
BCTX income_statement (annual, 2021-07-31) — Net Income: -13816200.00
BCTX income_statement (annual, 2021-07-31) — Net Income Common Stockholders: -13816200.00
BCTX income_statement (annual, 2021-07-31) — Net Income Continuous Operations: -13816200.00
BCTX income_statement (annual, 2021-07-31) — Net Income From Continuing And Discontinued Operation: -13816200.00
BCTX income_statement (annual, 2021-07-31) — Net Income From Continuing Operation Net Minority Interest: -13816200.00
BCTX cash_flow (annual, 2021-07-31) — Net Income From Continuing Operations: -13816200.00
BCTX income_statement (annual, 2021-07-31) — Net Income Including Noncontrolling Interests: -13816200.00
BCTX income_statement (annual, 2021-07-31) — Net Interest Income: -75405.00
BCTX cash_flow (annual, 2021-07-31) — Net Investment Purchase And Sale: 0.00
BCTX cash_flow (annual, 2021-07-31) — Net Issuance Payments Of Debt: -330398.00
BCTX cash_flow (annual, 2021-07-31) — Net Long Term Debt Issuance: -93935.00
BCTX income_statement (annual, 2021-07-31) — Net Non Operating Interest Income Expense: -75405.00
BCTX cash_flow (annual, 2021-07-31) — Net Short Term Debt Issuance: -330398.00
BCTX balance_sheet (annual, 2021-07-31) — Net Tangible Assets: 27426111.00
BCTX income_statement (annual, 2021-07-31) — Normalized EBITDA: -6953939.00
BCTX income_statement (annual, 2021-07-31) — Normalized Income: -7047749.00
BCTX cash_flow (annual, 2021-07-31) — Operating Cash Flow: -7750188.00
BCTX cash_flow (annual, 2021-07-31) — Operating Gains Losses: 4488864.00
BCTX income_statement (annual, 2021-07-31) — Operating Income: -6972344.00
BCTX income_statement (annual, 2021-07-31) — Operating Revenue: 0.00
BCTX balance_sheet (annual, 2021-07-31) — Ordinary Shares Number: 101797.00
BCTX balance_sheet (annual, 2021-07-31) — Other Equity Adjustments: -138684.00
BCTX balance_sheet (annual, 2021-07-31) — Other Equity Interest: 18371605.00
BCTX income_statement (annual, 2021-07-31) — Other Gand A: 4955136.00
BCTX income_statement (annual, 2021-07-31) — Other Income Expense: -6768451.00
BCTX balance_sheet (annual, 2021-07-31) — Other Intangible Assets: 245610.00
BCTX cash_flow (annual, 2021-07-31) — Other Non Cash Items: 1875772.00
BCTX income_statement (annual, 2021-07-31) — Other Operating Expenses: -3691.00
BCTX balance_sheet (annual, 2021-07-31) — Other Payable: 80967.00
BCTX income_statement (annual, 2021-07-31) — Other Special Charges: 141703.00
BCTX balance_sheet (annual, 2021-07-31) — Payables: 295083.00
BCTX balance_sheet (annual, 2021-07-31) — Payables And Accrued Expenses: 556795.00
BCTX balance_sheet (annual, 2021-07-31) — Prepaid Assets: 516891.00
BCTX income_statement (annual, 2021-07-31) — Pretax Income: -13816200.00
BCTX cash_flow (annual, 2021-07-31) — Proceeds From Stock Option Exercised: 13705685.00
BCTX balance_sheet (annual, 2021-07-31) — Receivables: 12574.00
BCTX income_statement (annual, 2021-07-31) — Reconciled Depreciation: 15256.00
BCTX income_statement (annual, 2021-07-31) — Rent And Landing Fees: 11939.00
BCTX income_statement (annual, 2021-07-31) — Rent Expense Supplemental: 11939.00
BCTX cash_flow (annual, 2021-07-31) — Repayment Of Debt: -546108.00
BCTX cash_flow (annual, 2021-07-31) — Repurchase Of Capital Stock: 0.00
BCTX income_statement (annual, 2021-07-31) — Research And Development: 2020899.00
BCTX balance_sheet (annual, 2021-07-31) — Retained Earnings: -29141897.00
BCTX income_statement (annual, 2021-07-31) — Salaries And Wages: 2147392.00
BCTX income_statement (annual, 2021-07-31) — Selling General And Administration: 4955136.00
BCTX balance_sheet (annual, 2021-07-31) — Share Issued: 101797.00
BCTX cash_flow (annual, 2021-07-31) — Short Term Debt Issuance: 215710.00
BCTX cash_flow (annual, 2021-07-31) — Short Term Debt Payments: -546108.00
BCTX income_statement (annual, 2021-07-31) — Special Income Charges: -141703.00
BCTX cash_flow (annual, 2021-07-31) — Stock Based Compensation: 1968226.00
BCTX balance_sheet (annual, 2021-07-31) — Stockholders Equity: 27671721.00
BCTX balance_sheet (annual, 2021-07-31) — Tangible Book Value: 27426111.00
BCTX income_statement (annual, 2021-07-31) — Tax Effect Of Unusual Items: 0.00
BCTX income_statement (annual, 2021-07-31) — Tax Rate For Calcs: 0.00
BCTX balance_sheet (annual, 2021-07-31) — Total Assets: 58043762.00
BCTX balance_sheet (annual, 2021-07-31) — Total Capitalization: 27697707.00
BCTX balance_sheet (annual, 2021-07-31) — Total Debt: 25986.00
BCTX balance_sheet (annual, 2021-07-31) — Total Equity Gross Minority Interest: 27671721.00
BCTX income_statement (annual, 2021-07-31) — Total Expenses: 6972344.00
BCTX balance_sheet (annual, 2021-07-31) — Total Liabilities Net Minority Interest: 30372041.00
BCTX balance_sheet (annual, 2021-07-31) — Total Non Current Assets: 245612.00
BCTX balance_sheet (annual, 2021-07-31) — Total Non Current Liabilities Net Minority Interest: 29815246.00
BCTX income_statement (annual, 2021-07-31) — Total Operating Income As Reported: -6973498.00
BCTX income_statement (annual, 2021-07-31) — Total Other Finance Cost: 4448957.00
BCTX income_statement (annual, 2021-07-31) — Total Unusual Items: -6768451.00
BCTX income_statement (annual, 2021-07-31) — Total Unusual Items Excluding Goodwill: -6768451.00
BCTX balance_sheet (annual, 2021-07-31) — Working Capital: 57241355.00
BCTX income_statement (annual, 2022-07-31) — +Operating Expense: 15285553.00
BCTX income_statement (annual, 2022-07-31) — +Total Revenue: 0.00
BCTX balance_sheet (annual, 2022-07-31) — Accounts Payable: 463280.00
BCTX balance_sheet (annual, 2022-07-31) — Accounts Receivable: 24103.00
BCTX balance_sheet (annual, 2022-07-31) — Additional Paid In Capital: 5228160.00
BCTX cash_flow (annual, 2022-07-31) — Amortization Cash Flow: 15272.00
BCTX cash_flow (annual, 2022-07-31) — Amortization Of Intangibles: 15272.00
BCTX income_statement (annual, 2022-07-31) — Basic Average Shares: 103293.00
BCTX income_statement (annual, 2022-07-31) — Basic EPS: -259.50
BCTX cash_flow (annual, 2022-07-31) — Beginning Cash Position: 57268685.00
BCTX balance_sheet (annual, 2022-07-31) — Capital Stock: 65589293.00
BCTX balance_sheet (annual, 2022-07-31) — Cash And Cash Equivalents: 41041652.00
BCTX balance_sheet (annual, 2022-07-31) — Cash Cash Equivalents And Short Term Investments: 41041652.00
BCTX cash_flow (annual, 2022-07-31) — Cash Flow From Continuing Financing Activities: -3742657.00
BCTX cash_flow (annual, 2022-07-31) — Cash Flow From Continuing Operating Activities: -12484376.00
BCTX cash_flow (annual, 2022-07-31) — Change In Account Payable: 249164.00
BCTX cash_flow (annual, 2022-07-31) — Change In Accrued Expense: 135128.00
BCTX cash_flow (annual, 2022-07-31) — Change In Payable: 249164.00
BCTX cash_flow (annual, 2022-07-31) — Change In Payables And Accrued Expense: 384292.00
BCTX cash_flow (annual, 2022-07-31) — Change In Prepaid Assets: -764054.00
BCTX cash_flow (annual, 2022-07-31) — Change In Receivables: -11530.00
BCTX cash_flow (annual, 2022-07-31) — Change In Working Capital: -391292.00
BCTX cash_flow (annual, 2022-07-31) — Changes In Cash: -16227033.00
BCTX balance_sheet (annual, 2022-07-31) — Common Stock: 65589293.00
BCTX balance_sheet (annual, 2022-07-31) — Common Stock Equity: 10328932.00
BCTX cash_flow (annual, 2022-07-31) — Common Stock Issuance: 0.00
BCTX cash_flow (annual, 2022-07-31) — Common Stock Payments: -10171732.00
BCTX balance_sheet (annual, 2022-07-31) — Current Accrued Expenses: 477807.00
BCTX balance_sheet (annual, 2022-07-31) — Current Assets: 42346700.00
BCTX balance_sheet (annual, 2022-07-31) — Current Liabilities: 941087.00
BCTX cash_flow (annual, 2022-07-31) — Depreciation Amortization Depletion: 15272.00
BCTX cash_flow (annual, 2022-07-31) — Depreciation And Amortization: 15272.00
BCTX balance_sheet (annual, 2022-07-31) — Derivative Product Liabilities: 31307022.00
BCTX income_statement (annual, 2022-07-31) — Diluted Average Shares: 103293.00
BCTX income_statement (annual, 2022-07-31) — Diluted EPS: -259.50
BCTX income_statement (annual, 2022-07-31) — Diluted NI Availto Com Stockholders: -26838903.00
BCTX income_statement (annual, 2022-07-31) — EBIT: -26837924.00
BCTX income_statement (annual, 2022-07-31) — EBITDA: -26822652.00
BCTX cash_flow (annual, 2022-07-31) — End Cash Position: 41041652.00
BCTX cash_flow (annual, 2022-07-31) — Financing Cash Flow: -3742657.00
BCTX cash_flow (annual, 2022-07-31) — Free Cash Flow: -12484376.00
BCTX cash_flow (annual, 2022-07-31) — Gain Loss On Investment Securities: 11658372.00
BCTX income_statement (annual, 2022-07-31) — Gain On Sale Of Security: -11689102.00
BCTX balance_sheet (annual, 2022-07-31) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTX income_statement (annual, 2022-07-31) — General And Administrative Expense: 7267452.00
BCTX balance_sheet (annual, 2022-07-31) — Goodwill And Other Intangible Assets: 230339.00
BCTX income_statement (annual, 2022-07-31) — Interest Expense: 979.00
BCTX income_statement (annual, 2022-07-31) — Interest Expense Non Operating: 979.00
BCTX income_statement (annual, 2022-07-31) — Interest Income: 136731.00
BCTX income_statement (annual, 2022-07-31) — Interest Income Non Operating: 136731.00
BCTX balance_sheet (annual, 2022-07-31) — Invested Capital: 10328932.00
BCTX balance_sheet (annual, 2022-07-31) — Investments And Advances: 2.00
BCTX cash_flow (annual, 2022-07-31) — Issuance Of Capital Stock: 0.00
BCTX cash_flow (annual, 2022-07-31) — Issuance Of Debt: 0.00
BCTX cash_flow (annual, 2022-07-31) — Net Common Stock Issuance: -10171732.00
BCTX income_statement (annual, 2022-07-31) — Net Income: -26838903.00
BCTX income_statement (annual, 2022-07-31) — Net Income Common Stockholders: -26838903.00
BCTX income_statement (annual, 2022-07-31) — Net Income Continuous Operations: -26838903.00
BCTX income_statement (annual, 2022-07-31) — Net Income From Continuing And Discontinued Operation: -26838903.00
BCTX income_statement (annual, 2022-07-31) — Net Income From Continuing Operation Net Minority Interest: -26838903.00
BCTX cash_flow (annual, 2022-07-31) — Net Income From Continuing Operations: -26838903.00
BCTX income_statement (annual, 2022-07-31) — Net Income Including Noncontrolling Interests: -26838903.00
BCTX income_statement (annual, 2022-07-31) — Net Interest Income: 135752.00
BCTX cash_flow (annual, 2022-07-31) — Net Issuance Payments Of Debt: 0.00
BCTX income_statement (annual, 2022-07-31) — Net Non Operating Interest Income Expense: 135752.00
BCTX cash_flow (annual, 2022-07-31) — Net Other Financing Charges: -80693.00
BCTX cash_flow (annual, 2022-07-31) — Net Short Term Debt Issuance: 0.00
BCTX balance_sheet (annual, 2022-07-31) — Net Tangible Assets: 10098593.00
BCTX income_statement (annual, 2022-07-31) — Normalized EBITDA: -15133550.00
BCTX income_statement (annual, 2022-07-31) — Normalized Income: -15149801.00
BCTX cash_flow (annual, 2022-07-31) — Operating Cash Flow: -12484376.00
BCTX cash_flow (annual, 2022-07-31) — Operating Gains Losses: 11658372.00
BCTX income_statement (annual, 2022-07-31) — Operating Income: -15285553.00
BCTX income_statement (annual, 2022-07-31) — Operating Revenue: 0.00
BCTX balance_sheet (annual, 2022-07-31) — Ordinary Shares Number: 103453.00
BCTX balance_sheet (annual, 2022-07-31) — Other Equity Adjustments: -138684.00
BCTX income_statement (annual, 2022-07-31) — Other Gand A: 7267452.00
BCTX income_statement (annual, 2022-07-31) — Other Income Expense: -11689102.00
BCTX balance_sheet (annual, 2022-07-31) — Other Intangible Assets: 230339.00
BCTX cash_flow (annual, 2022-07-31) — Other Non Cash Items: -2409.00
BCTX income_statement (annual, 2022-07-31) — Other Operating Expenses: -3388.00
BCTX balance_sheet (annual, 2022-07-31) — Payables: 463280.00
BCTX balance_sheet (annual, 2022-07-31) — Payables And Accrued Expenses: 941087.00
BCTX balance_sheet (annual, 2022-07-31) — Prepaid Assets: 1280945.00
BCTX income_statement (annual, 2022-07-31) — Pretax Income: -26838903.00
BCTX cash_flow (annual, 2022-07-31) — Proceeds From Stock Option Exercised: 6509768.00
BCTX balance_sheet (annual, 2022-07-31) — Receivables: 24103.00
BCTX income_statement (annual, 2022-07-31) — Reconciled Depreciation: 15272.00
BCTX cash_flow (annual, 2022-07-31) — Repayment Of Debt: 0.00
BCTX cash_flow (annual, 2022-07-31) — Repurchase Of Capital Stock: -10171732.00
BCTX income_statement (annual, 2022-07-31) — Research And Development: 8021489.00
BCTX balance_sheet (annual, 2022-07-31) — Retained Earnings: -60349837.00
BCTX income_statement (annual, 2022-07-31) — Selling General And Administration: 7267452.00
BCTX balance_sheet (annual, 2022-07-31) — Share Issued: 103453.00
BCTX cash_flow (annual, 2022-07-31) — Short Term Debt Issuance: 0.00
BCTX cash_flow (annual, 2022-07-31) — Short Term Debt Payments: 0.00
BCTX income_statement (annual, 2022-07-31) — Special Income Charges: 0.00
BCTX cash_flow (annual, 2022-07-31) — Stock Based Compensation: 3074584.00
BCTX balance_sheet (annual, 2022-07-31) — Stockholders Equity: 10328932.00
BCTX balance_sheet (annual, 2022-07-31) — Tangible Book Value: 10098593.00
BCTX income_statement (annual, 2022-07-31) — Tax Effect Of Unusual Items: 0.00
BCTX income_statement (annual, 2022-07-31) — Tax Rate For Calcs: 0.00
BCTX balance_sheet (annual, 2022-07-31) — Total Assets: 42577041.00
BCTX balance_sheet (annual, 2022-07-31) — Total Capitalization: 10328932.00
BCTX balance_sheet (annual, 2022-07-31) — Total Equity Gross Minority Interest: 10328932.00
BCTX income_statement (annual, 2022-07-31) — Total Expenses: 15285553.00
BCTX balance_sheet (annual, 2022-07-31) — Total Liabilities Net Minority Interest: 32248109.00
BCTX balance_sheet (annual, 2022-07-31) — Total Non Current Assets: 230341.00
BCTX balance_sheet (annual, 2022-07-31) — Total Non Current Liabilities Net Minority Interest: 31307022.00
BCTX income_statement (annual, 2022-07-31) — Total Operating Income As Reported: -15288941.00
BCTX income_statement (annual, 2022-07-31) — Total Other Finance Cost: 11658372.00
BCTX income_statement (annual, 2022-07-31) — Total Unusual Items: -11689102.00
BCTX income_statement (annual, 2022-07-31) — Total Unusual Items Excluding Goodwill: -11689102.00
BCTX balance_sheet (annual, 2022-07-31) — Working Capital: 41405613.00
BCTX income_statement (annual, 2023-07-31) — +Operating Expense: 23272264.00
BCTX income_statement (annual, 2023-07-31) — +Total Revenue: 0.00
BCTX balance_sheet (annual, 2023-07-31) — Accounts Payable: 1123739.00
BCTX balance_sheet (annual, 2023-07-31) — Accounts Receivable: 18873.00
BCTX balance_sheet (annual, 2023-07-31) — Accumulated Depreciation: 0.00
BCTX balance_sheet (annual, 2023-07-31) — Additional Paid In Capital: 7421950.00
BCTX cash_flow (annual, 2023-07-31) — Amortization Cash Flow: 15271.00
BCTX cash_flow (annual, 2023-07-31) — Amortization Of Intangibles: 15271.00
BCTX income_statement (annual, 2023-07-31) — Basic Average Shares: 104131.00
BCTX income_statement (annual, 2023-07-31) — Basic EPS: -195.00
BCTX cash_flow (annual, 2023-07-31) — Beginning Cash Position: 41041652.00
BCTX balance_sheet (annual, 2023-07-31) — Capital Stock: 69591784.00
BCTX balance_sheet (annual, 2023-07-31) — Cash And Cash Equivalents: 21251092.00
BCTX balance_sheet (annual, 2023-07-31) — Cash Cash Equivalents And Short Term Investments: 21251092.00
BCTX cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Financing Activities: 3954300.00
BCTX cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Investing Activities: 0.00
BCTX cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Operating Activities: -23744860.00
BCTX cash_flow (annual, 2023-07-31) — Change In Account Payable: 660459.00
BCTX cash_flow (annual, 2023-07-31) — Change In Accrued Expense: 199911.00
BCTX cash_flow (annual, 2023-07-31) — Change In Payable: 660459.00
BCTX cash_flow (annual, 2023-07-31) — Change In Payables And Accrued Expense: 860370.00
BCTX cash_flow (annual, 2023-07-31) — Change In Prepaid Assets: -4397597.00
BCTX cash_flow (annual, 2023-07-31) — Change In Receivables: 5230.00
BCTX cash_flow (annual, 2023-07-31) — Change In Working Capital: -3531997.00
BCTX cash_flow (annual, 2023-07-31) — Changes In Cash: -19790560.00
BCTX balance_sheet (annual, 2023-07-31) — Common Stock: 69591784.00
BCTX balance_sheet (annual, 2023-07-31) — Common Stock Equity: -3777181.00
BCTX cash_flow (annual, 2023-07-31) — Common Stock Issuance: 4000000.00
BCTX cash_flow (annual, 2023-07-31) — Common Stock Payments: -47294.00
BCTX balance_sheet (annual, 2023-07-31) — Current Accrued Expenses: 677718.00
BCTX balance_sheet (annual, 2023-07-31) — Current Assets: 26948507.00
BCTX balance_sheet (annual, 2023-07-31) — Current Liabilities: 1801457.00
BCTX cash_flow (annual, 2023-07-31) — Depreciation: 0.00
BCTX cash_flow (annual, 2023-07-31) — Depreciation Amortization Depletion: 15271.00
BCTX cash_flow (annual, 2023-07-31) — Depreciation And Amortization: 15271.00
BCTX balance_sheet (annual, 2023-07-31) — Derivative Product Liabilities: 29139301.00
BCTX income_statement (annual, 2023-07-31) — Diluted Average Shares: 104131.00
BCTX income_statement (annual, 2023-07-31) — Diluted EPS: -195.00
BCTX income_statement (annual, 2023-07-31) — Diluted NI Availto Com Stockholders: -20302394.00
BCTX income_statement (annual, 2023-07-31) — EBIT: -23272264.00
BCTX income_statement (annual, 2023-07-31) — EBITDA: -23256993.00
BCTX income_statement (annual, 2023-07-31) — Earnings From Equity Interest: 0.00
BCTX cash_flow (annual, 2023-07-31) — Earnings Losses From Equity Investments: 0.00
BCTX cash_flow (annual, 2023-07-31) — End Cash Position: 21251092.00
BCTX cash_flow (annual, 2023-07-31) — Financing Cash Flow: 3954300.00
BCTX cash_flow (annual, 2023-07-31) — Free Cash Flow: -23744860.00
BCTX cash_flow (annual, 2023-07-31) — Gain Loss On Investment Securities: -2119530.00
BCTX income_statement (annual, 2023-07-31) — Gain On Sale Of Security: 2078657.00
BCTX balance_sheet (annual, 2023-07-31) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTX income_statement (annual, 2023-07-31) — General And Administrative Expense: 7935626.00
BCTX balance_sheet (annual, 2023-07-31) — Goodwill And Other Intangible Assets: 215068.00
BCTX balance_sheet (annual, 2023-07-31) — Gross PPE: 0.00
BCTX income_statement (annual, 2023-07-31) — Interest Expense: 0.00
BCTX income_statement (annual, 2023-07-31) — Interest Expense Non Operating: 0.00
BCTX income_statement (annual, 2023-07-31) — Interest Income: 891213.00
BCTX income_statement (annual, 2023-07-31) — Interest Income Non Operating: 891213.00
BCTX balance_sheet (annual, 2023-07-31) — Invested Capital: -3777181.00
BCTX cash_flow (annual, 2023-07-31) — Investing Cash Flow: 0.00
BCTX balance_sheet (annual, 2023-07-31) — Investments And Advances: 2.00
BCTX balance_sheet (annual, 2023-07-31) — Investmentsin Subsidiariesat Cost: 0.00
BCTX cash_flow (annual, 2023-07-31) — Issuance Of Capital Stock: 4000000.00
BCTX balance_sheet (annual, 2023-07-31) — Long Term Equity Investment: 0.00
BCTX balance_sheet (annual, 2023-07-31) — Minority Interest: 0.00
BCTX income_statement (annual, 2023-07-31) — Minority Interests: 0.00
BCTX cash_flow (annual, 2023-07-31) — Net Business Purchase And Sale: 0.00
BCTX cash_flow (annual, 2023-07-31) — Net Common Stock Issuance: 3952706.00
BCTX income_statement (annual, 2023-07-31) — Net Income: -20302394.00
BCTX income_statement (annual, 2023-07-31) — Net Income Common Stockholders: -20302394.00
BCTX income_statement (annual, 2023-07-31) — Net Income Continuous Operations: -20302394.00
BCTX income_statement (annual, 2023-07-31) — Net Income From Continuing And Discontinued Operation: -20302394.00
BCTX income_statement (annual, 2023-07-31) — Net Income From Continuing Operation Net Minority Interest: -20302394.00
BCTX cash_flow (annual, 2023-07-31) — Net Income From Continuing Operations: -20302394.00
BCTX income_statement (annual, 2023-07-31) — Net Income Including Noncontrolling Interests: -20302394.00
BCTX income_statement (annual, 2023-07-31) — Net Interest Income: 891213.00
BCTX income_statement (annual, 2023-07-31) — Net Non Operating Interest Income Expense: 891213.00
BCTX balance_sheet (annual, 2023-07-31) — Net PPE: 0.00
BCTX cash_flow (annual, 2023-07-31) — Net PPE Purchase And Sale: 0.00
BCTX balance_sheet (annual, 2023-07-31) — Net Tangible Assets: -3992249.00
BCTX balance_sheet (annual, 2023-07-31) — Non Current Prepaid Assets: 0.00
BCTX income_statement (annual, 2023-07-31) — Normalized EBITDA: -25335650.00
BCTX income_statement (annual, 2023-07-31) — Normalized Income: -22381051.00
BCTX cash_flow (annual, 2023-07-31) — Operating Cash Flow: -23744860.00
BCTX cash_flow (annual, 2023-07-31) — Operating Gains Losses: -2119530.00
BCTX income_statement (annual, 2023-07-31) — Operating Income: -23272264.00
BCTX income_statement (annual, 2023-07-31) — Operating Revenue: 0.00
BCTX balance_sheet (annual, 2023-07-31) — Ordinary Shares Number: 106544.00
BCTX balance_sheet (annual, 2023-07-31) — Other Equity Adjustments: -138684.00
BCTX balance_sheet (annual, 2023-07-31) — Other Equity Interest: 7421950.00
BCTX income_statement (annual, 2023-07-31) — Other Gand A: 7935626.00
BCTX income_statement (annual, 2023-07-31) — Other Income Expense: 2078657.00
BCTX balance_sheet (annual, 2023-07-31) — Other Intangible Assets: 215068.00
BCTX balance_sheet (annual, 2023-07-31) — Other Receivables: 717742.00
BCTX balance_sheet (annual, 2023-07-31) — Payables: 1123739.00
BCTX balance_sheet (annual, 2023-07-31) — Payables And Accrued Expenses: 1801457.00
BCTX balance_sheet (annual, 2023-07-31) — Prepaid Assets: 4979673.00
BCTX income_statement (annual, 2023-07-31) — Pretax Income: -20302394.00
BCTX cash_flow (annual, 2023-07-31) — Proceeds From Stock Option Exercised: 1594.00
BCTX cash_flow (annual, 2023-07-31) — Purchase Of Business: 0.00
BCTX cash_flow (annual, 2023-07-31) — Purchase Of PPE: 0.00
BCTX balance_sheet (annual, 2023-07-31) — Receivables: 717742.00
BCTX income_statement (annual, 2023-07-31) — Reconciled Depreciation: 15271.00
BCTX cash_flow (annual, 2023-07-31) — Repurchase Of Capital Stock: -47294.00
BCTX income_statement (annual, 2023-07-31) — Research And Development: 15336638.00
BCTX balance_sheet (annual, 2023-07-31) — Retained Earnings: -80652231.00
BCTX income_statement (annual, 2023-07-31) — Selling General And Administration: 7935626.00
BCTX balance_sheet (annual, 2023-07-31) — Share Issued: 106544.00
BCTX cash_flow (annual, 2023-07-31) — Stock Based Compensation: 2193790.00
BCTX balance_sheet (annual, 2023-07-31) — Stockholders Equity: -3777181.00
BCTX balance_sheet (annual, 2023-07-31) — Tangible Book Value: -3992249.00
BCTX income_statement (annual, 2023-07-31) — Tax Effect Of Unusual Items: 0.00
BCTX income_statement (annual, 2023-07-31) — Tax Rate For Calcs: 0.00
BCTX balance_sheet (annual, 2023-07-31) — Total Assets: 27163577.00
BCTX balance_sheet (annual, 2023-07-31) — Total Capitalization: -3777181.00
BCTX balance_sheet (annual, 2023-07-31) — Total Equity Gross Minority Interest: -3777181.00
BCTX income_statement (annual, 2023-07-31) — Total Expenses: 23272264.00
BCTX balance_sheet (annual, 2023-07-31) — Total Liabilities Net Minority Interest: 30940758.00
BCTX balance_sheet (annual, 2023-07-31) — Total Non Current Assets: 215070.00
BCTX balance_sheet (annual, 2023-07-31) — Total Non Current Liabilities Net Minority Interest: 29139301.00
BCTX income_statement (annual, 2023-07-31) — Total Operating Income As Reported: -23272264.00
BCTX income_statement (annual, 2023-07-31) — Total Unusual Items: 2078657.00
BCTX income_statement (annual, 2023-07-31) — Total Unusual Items Excluding Goodwill: 2078657.00
BCTX balance_sheet (annual, 2023-07-31) — Working Capital: 25147050.00
BCTX income_statement (annual, 2024-07-31) — +Operating Expense: 33330076.00
BCTX income_statement (annual, 2024-07-31) — +Total Revenue: 0.00
BCTX balance_sheet (annual, 2024-07-31) — Accounts Payable: 7170781.00
BCTX balance_sheet (annual, 2024-07-31) — Accumulated Depreciation: -68626.00
BCTX cash_flow (annual, 2024-07-31) — Amortization Cash Flow: 15271.00
BCTX cash_flow (annual, 2024-07-31) — Amortization Of Intangibles: 15271.00
BCTX income_statement (annual, 2024-07-31) — Basic Average Shares: 109699.00
BCTX income_statement (annual, 2024-07-31) — Basic EPS: -43.68
BCTX cash_flow (annual, 2024-07-31) — Beginning Cash Position: 21251092.00
BCTX cash_flow (annual, 2024-07-31) — Capital Expenditure: -456801.00
BCTX balance_sheet (annual, 2024-07-31) — Capital Stock: 72166414.00
BCTX balance_sheet (annual, 2024-07-31) — Cash And Cash Equivalents: 862089.00
BCTX balance_sheet (annual, 2024-07-31) — Cash Cash Equivalents And Short Term Investments: 862089.00
BCTX cash_flow (annual, 2024-07-31) — Cash Flow From Continuing Financing Activities: 4418926.00
BCTX cash_flow (annual, 2024-07-31) — Cash Flow From Continuing Investing Activities: -681801.00
BCTX cash_flow (annual, 2024-07-31) — Cash Flow From Continuing Operating Activities: -24126128.00
BCTX cash_flow (annual, 2024-07-31) — Change In Account Payable: 6047042.00
BCTX cash_flow (annual, 2024-07-31) — Change In Accrued Expense: -387339.00
BCTX cash_flow (annual, 2024-07-31) — Change In Payable: 6047042.00
BCTX cash_flow (annual, 2024-07-31) — Change In Payables And Accrued Expense: 5659703.00
BCTX cash_flow (annual, 2024-07-31) — Change In Prepaid Assets: 2126282.00
BCTX cash_flow (annual, 2024-07-31) — Change In Receivables: -732578.00
BCTX cash_flow (annual, 2024-07-31) — Change In Working Capital: 7053407.00
BCTX cash_flow (annual, 2024-07-31) — Changes In Cash: -20389003.00
BCTX balance_sheet (annual, 2024-07-31) — Common Stock: 72166414.00
BCTX balance_sheet (annual, 2024-07-31) — Common Stock Equity: -2382410.00
BCTX cash_flow (annual, 2024-07-31) — Common Stock Issuance: 4418926.00
BCTX cash_flow (annual, 2024-07-31) — Common Stock Payments: 0.00
BCTX balance_sheet (annual, 2024-07-31) — Current Accrued Expenses: 290376.00
BCTX balance_sheet (annual, 2024-07-31) — Current Assets: 3653854.00
BCTX balance_sheet (annual, 2024-07-31) — Current Liabilities: 7461157.00
BCTX cash_flow (annual, 2024-07-31) — Depreciation: 68626.00
BCTX cash_flow (annual, 2024-07-31) — Depreciation Amortization Depletion: 83897.00
BCTX cash_flow (annual, 2024-07-31) — Depreciation And Amortization: 83897.00
BCTX balance_sheet (annual, 2024-07-31) — Derivative Product Liabilities: 1096036.00
BCTX income_statement (annual, 2024-07-31) — Diluted Average Shares: 109699.00
BCTX income_statement (annual, 2024-07-31) — Diluted EPS: -43.68
BCTX income_statement (annual, 2024-07-31) — Diluted NI Availto Com Stockholders: -4791466.00
BCTX income_statement (annual, 2024-07-31) — EBIT: -4931548.00
BCTX income_statement (annual, 2024-07-31) — EBITDA: -4847651.00
BCTX income_statement (annual, 2024-07-31) — Earnings From Equity Interest: -106510.00
BCTX cash_flow (annual, 2024-07-31) — Earnings Losses From Equity Investments: 106510.00
BCTX cash_flow (annual, 2024-07-31) — End Cash Position: 862089.00
BCTX cash_flow (annual, 2024-07-31) — Financing Cash Flow: 4418926.00
BCTX cash_flow (annual, 2024-07-31) — Free Cash Flow: -24582929.00
BCTX cash_flow (annual, 2024-07-31) — Gain Loss On Investment Securities: -28242472.00
BCTX income_statement (annual, 2024-07-31) — Gain On Sale Of Security: 28217020.00
BCTX balance_sheet (annual, 2024-07-31) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTX income_statement (annual, 2024-07-31) — General And Administrative Expense: 6152269.00
BCTX balance_sheet (annual, 2024-07-31) — Goodwill And Other Intangible Assets: 199796.00
BCTX balance_sheet (annual, 2024-07-31) — Gross PPE: 456801.00
BCTX income_statement (annual, 2024-07-31) — Interest Income: 288018.00
BCTX income_statement (annual, 2024-07-31) — Interest Income Non Operating: 288018.00
BCTX balance_sheet (annual, 2024-07-31) — Invested Capital: -2382410.00
BCTX cash_flow (annual, 2024-07-31) — Investing Cash Flow: -681801.00
BCTX balance_sheet (annual, 2024-07-31) — Investments And Advances: 418490.00
BCTX balance_sheet (annual, 2024-07-31) — Investmentsin Subsidiariesat Cost: 418490.00
BCTX cash_flow (annual, 2024-07-31) — Issuance Of Capital Stock: 4418926.00
BCTX balance_sheet (annual, 2024-07-31) — Long Term Equity Investment: 418490.00
BCTX balance_sheet (annual, 2024-07-31) — Minority Interest: -302522.00
BCTX income_statement (annual, 2024-07-31) — Minority Interests: 140082.00
BCTX cash_flow (annual, 2024-07-31) — Net Business Purchase And Sale: -225000.00
BCTX cash_flow (annual, 2024-07-31) — Net Common Stock Issuance: 4418926.00
BCTX income_statement (annual, 2024-07-31) — Net Income: -4791466.00
BCTX income_statement (annual, 2024-07-31) — Net Income Common Stockholders: -4791466.00
BCTX income_statement (annual, 2024-07-31) — Net Income Continuous Operations: -4931548.00
BCTX income_statement (annual, 2024-07-31) — Net Income From Continuing And Discontinued Operation: -4791466.00
BCTX income_statement (annual, 2024-07-31) — Net Income From Continuing Operation Net Minority Interest: -4791466.00
BCTX cash_flow (annual, 2024-07-31) — Net Income From Continuing Operations: -4931548.00
BCTX income_statement (annual, 2024-07-31) — Net Income Including Noncontrolling Interests: -4931548.00
BCTX income_statement (annual, 2024-07-31) — Net Interest Income: 288018.00
BCTX income_statement (annual, 2024-07-31) — Net Non Operating Interest Income Expense: 288018.00
BCTX balance_sheet (annual, 2024-07-31) — Net PPE: 388175.00
BCTX cash_flow (annual, 2024-07-31) — Net PPE Purchase And Sale: -456801.00
BCTX balance_sheet (annual, 2024-07-31) — Net Tangible Assets: -2582206.00
BCTX balance_sheet (annual, 2024-07-31) — Non Current Prepaid Assets: 1211946.00
BCTX income_statement (annual, 2024-07-31) — Normalized EBITDA: -33064671.00
BCTX income_statement (annual, 2024-07-31) — Normalized Income: -33008486.00
BCTX cash_flow (annual, 2024-07-31) — Operating Cash Flow: -24126128.00
BCTX cash_flow (annual, 2024-07-31) — Operating Gains Losses: -28135962.00
BCTX income_statement (annual, 2024-07-31) — Operating Income: -33330076.00
BCTX income_statement (annual, 2024-07-31) — Operating Revenue: 0.00
BCTX balance_sheet (annual, 2024-07-31) — Ordinary Shares Number: 121897.00
BCTX balance_sheet (annual, 2024-07-31) — Other Equity Adjustments: -138684.00
BCTX balance_sheet (annual, 2024-07-31) — Other Equity Interest: 11033557.00
BCTX income_statement (annual, 2024-07-31) — Other Gand A: 6152269.00
BCTX income_statement (annual, 2024-07-31) — Other Income Expense: 28110510.00
BCTX balance_sheet (annual, 2024-07-31) — Other Intangible Assets: 199796.00
BCTX balance_sheet (annual, 2024-07-31) — Other Properties: 456801.00
BCTX balance_sheet (annual, 2024-07-31) — Other Receivables: 1369016.00
BCTX balance_sheet (annual, 2024-07-31) — Payables: 7170781.00
BCTX balance_sheet (annual, 2024-07-31) — Payables And Accrued Expenses: 7461157.00
BCTX balance_sheet (annual, 2024-07-31) — Prepaid Assets: 1422749.00
BCTX income_statement (annual, 2024-07-31) — Pretax Income: -4931548.00
BCTX cash_flow (annual, 2024-07-31) — Proceeds From Stock Option Exercised: 0.00
BCTX cash_flow (annual, 2024-07-31) — Purchase Of Business: -225000.00
BCTX cash_flow (annual, 2024-07-31) — Purchase Of PPE: -456801.00
BCTX balance_sheet (annual, 2024-07-31) — Receivables: 1369016.00
BCTX income_statement (annual, 2024-07-31) — Reconciled Depreciation: 83897.00
BCTX cash_flow (annual, 2024-07-31) — Repurchase Of Capital Stock: 0.00
BCTX income_statement (annual, 2024-07-31) — Research And Development: 27177807.00
BCTX balance_sheet (annual, 2024-07-31) — Retained Earnings: -85443697.00
BCTX income_statement (annual, 2024-07-31) — Selling General And Administration: 6152269.00
BCTX balance_sheet (annual, 2024-07-31) — Share Issued: 121897.00
BCTX cash_flow (annual, 2024-07-31) — Stock Based Compensation: 1804078.00
BCTX balance_sheet (annual, 2024-07-31) — Stockholders Equity: -2382410.00
BCTX balance_sheet (annual, 2024-07-31) — Tangible Book Value: -2582206.00
BCTX income_statement (annual, 2024-07-31) — Tax Effect Of Unusual Items: 0.00
BCTX income_statement (annual, 2024-07-31) — Tax Rate For Calcs: 0.00
BCTX balance_sheet (annual, 2024-07-31) — Total Assets: 5872261.00
BCTX balance_sheet (annual, 2024-07-31) — Total Capitalization: -2382410.00
BCTX balance_sheet (annual, 2024-07-31) — Total Equity Gross Minority Interest: -2684932.00
BCTX income_statement (annual, 2024-07-31) — Total Expenses: 33330076.00
BCTX balance_sheet (annual, 2024-07-31) — Total Liabilities Net Minority Interest: 8557193.00
BCTX balance_sheet (annual, 2024-07-31) — Total Non Current Assets: 2218407.00
BCTX balance_sheet (annual, 2024-07-31) — Total Non Current Liabilities Net Minority Interest: 1096036.00
BCTX income_statement (annual, 2024-07-31) — Total Operating Income As Reported: -33330076.00
BCTX income_statement (annual, 2024-07-31) — Total Unusual Items: 28217020.00
BCTX income_statement (annual, 2024-07-31) — Total Unusual Items Excluding Goodwill: 28217020.00
BCTX balance_sheet (annual, 2024-07-31) — Working Capital: -3807303.00
BCTX income_statement (quarterly, 2024-10-31) — +Operating Expense: 5152832.00
BCTX income_statement (quarterly, 2024-10-31) — +Total Revenue: 0.00
BCTX balance_sheet (quarterly, 2024-10-31) — Accounts Payable: 4233968.00
BCTX balance_sheet (quarterly, 2024-10-31) — Accounts Receivable: 2426830.00
BCTX cash_flow (quarterly, 2024-10-31) — Amortization Cash Flow: 3818.00
BCTX cash_flow (quarterly, 2024-10-31) — Amortization Of Intangibles: 3818.00
BCTX income_statement (quarterly, 2024-10-31) — Average Dilution Earnings: 0.00
BCTX income_statement (quarterly, 2024-10-31) — Basic Average Shares: 177606.00
BCTX income_statement (quarterly, 2024-10-31) — Basic EPS: -32.67
BCTX cash_flow (quarterly, 2024-10-31) — Beginning Cash Position: 862089.00
BCTX balance_sheet (quarterly, 2024-10-31) — Capital Stock: 82040741.00
BCTX balance_sheet (quarterly, 2024-10-31) — Cash And Cash Equivalents: 5792265.00
BCTX balance_sheet (quarterly, 2024-10-31) — Cash Cash Equivalents And Short Term Investments: 5792265.00
BCTX cash_flow (quarterly, 2024-10-31) — Cash Flow From Continuing Financing Activities: 11960252.00
BCTX cash_flow (quarterly, 2024-10-31) — Cash Flow From Continuing Investing Activities: -75000.00
BCTX cash_flow (quarterly, 2024-10-31) — Cash Flow From Continuing Operating Activities: -6955076.00
BCTX cash_flow (quarterly, 2024-10-31) — Change In Account Payable: -2936813.00
BCTX cash_flow (quarterly, 2024-10-31) — Change In Accrued Expense: 464292.00
BCTX cash_flow (quarterly, 2024-10-31) — Change In Payable: -2936813.00
BCTX cash_flow (quarterly, 2024-10-31) — Change In Payables And Accrued Expense: -2472521.00
BCTX cash_flow (quarterly, 2024-10-31) — Change In Prepaid Assets: -371853.00
BCTX cash_flow (quarterly, 2024-10-31) — Change In Receivables: 364935.00
BCTX cash_flow (quarterly, 2024-10-31) — Change In Working Capital: -2107586.00
BCTX cash_flow (quarterly, 2024-10-31) — Changes In Cash: 4930176.00
BCTX balance_sheet (quarterly, 2024-10-31) — Common Stock: 82040741.00
BCTX balance_sheet (quarterly, 2024-10-31) — Common Stock Equity: 4042638.00
BCTX cash_flow (quarterly, 2024-10-31) — Common Stock Issuance: 11667001.00
BCTX balance_sheet (quarterly, 2024-10-31) — Current Accrued Expenses: 754668.00
BCTX balance_sheet (quarterly, 2024-10-31) — Current Assets: 8219095.00
BCTX balance_sheet (quarterly, 2024-10-31) — Current Liabilities: 4988636.00
BCTX cash_flow (quarterly, 2024-10-31) — Depreciation: 22839.00
BCTX cash_flow (quarterly, 2024-10-31) — Depreciation Amortization Depletion: 26657.00
BCTX cash_flow (quarterly, 2024-10-31) — Depreciation And Amortization: 26657.00
BCTX balance_sheet (quarterly, 2024-10-31) — Derivative Product Liabilities: 1712679.00
BCTX income_statement (quarterly, 2024-10-31) — Diluted Average Shares: 177606.00
BCTX income_statement (quarterly, 2024-10-31) — Diluted EPS: -32.67
BCTX income_statement (quarterly, 2024-10-31) — Diluted NI Availto Com Stockholders: -5802175.00
BCTX income_statement (quarterly, 2024-10-31) — EBIT: -5152832.00
BCTX income_statement (quarterly, 2024-10-31) — EBITDA: -5126175.00
BCTX income_statement (quarterly, 2024-10-31) — Earnings From Equity Interest: -71515.00
BCTX cash_flow (quarterly, 2024-10-31) — Earnings Losses From Equity Investments: 71515.00
BCTX cash_flow (quarterly, 2024-10-31) — End Cash Position: 5792265.00
BCTX cash_flow (quarterly, 2024-10-31) — Financing Cash Flow: 11960252.00
BCTX cash_flow (quarterly, 2024-10-31) — Free Cash Flow: -6955076.00
BCTX cash_flow (quarterly, 2024-10-31) — Gain Loss On Investment Securities: 616643.00
BCTX income_statement (quarterly, 2024-10-31) — Gain On Sale Of Security: -617979.00
BCTX balance_sheet (quarterly, 2024-10-31) — Gains Losses Not Affecting Retained Earnings: -138684.00
BCTX income_statement (quarterly, 2024-10-31) — General And Administrative Expense: 1487491.00
BCTX balance_sheet (quarterly, 2024-10-31) — Goodwill And Other Intangible Assets: 195978.00
BCTX income_statement (quarterly, 2024-10-31) — Interest Income: 13050.00
BCTX income_statement (quarterly, 2024-10-31) — Interest Income Non Operating: 13050.00
BCTX balance_sheet (quarterly, 2024-10-31) — Invested Capital: 4042638.00
BCTX cash_flow (quarterly, 2024-10-31) — Investing Cash Flow: -75000.00
BCTX balance_sheet (quarterly, 2024-10-31) — Investments And Advances: 421975.00
BCTX balance_sheet (quarterly, 2024-10-31) — Investmentsin Subsidiariesat Cost: 421975.00
BCTX cash_flow (quarterly, 2024-10-31) — Issuance Of Capital Stock: 11667001.00
BCTX balance_sheet (quarterly, 2024-10-31) — Long Term Equity Investment: 421975.00
BCTX balance_sheet (quarterly, 2024-10-31) — Minority Interest: -329623.00
BCTX income_statement (quarterly, 2024-10-31) — Minority Interests: 27101.00
BCTX cash_flow (quarterly, 2024-10-31) — Net Business Purchase And Sale: -75000.00
BCTX cash_flow (quarterly, 2024-10-31) — Net Common Stock Issuance: 11667001.00
BCTX income_statement (quarterly, 2024-10-31) — Net Income: -5802175.00
BCTX income_statement (quarterly, 2024-10-31) — Net Income Common Stockholders: -5802175.00
BCTX income_statement (quarterly, 2024-10-31) — Net Income Continuous Operations: -5829276.00
BCTX income_statement (quarterly, 2024-10-31) — Net Income From Continuing And Discontinued Operation: -5802175.00
BCTX income_statement (quarterly, 2024-10-31) — Net Income From Continuing Operation Net Minority Interest: -5802175.00
BCTX cash_flow (quarterly, 2024-10-31) — Net Income From Continuing Operations: -5829276.00
BCTX income_statement (quarterly, 2024-10-31) — Net Income Including Noncontrolling Interests: -5829276.00
BCTX income_statement (quarterly, 2024-10-31) — Net Interest Income: 13050.00
BCTX income_statement (quarterly, 2024-10-31) — Net Non Operating Interest Income Expense: 13050.00
BCTX balance_sheet (quarterly, 2024-10-31) — Net PPE: 365336.00
BCTX balance_sheet (quarterly, 2024-10-31) — Net Tangible Assets: 3846660.00
BCTX balance_sheet (quarterly, 2024-10-31) — Non Current Prepaid Assets: 1211946.00
BCTX income_statement (quarterly, 2024-10-31) — Normalized EBITDA: -4508196.00
BCTX income_statement (quarterly, 2024-10-31) — Normalized Income: -5184196.00
BCTX cash_flow (quarterly, 2024-10-31) — Operating Cash Flow: -6955076.00
BCTX cash_flow (quarterly, 2024-10-31) — Operating Gains Losses: 688158.00
BCTX income_statement (quarterly, 2024-10-31) — Operating Income: -5152832.00
BCTX income_statement (quarterly, 2024-10-31) — Operating Revenue: 0.00
BCTX balance_sheet (quarterly, 2024-10-31) — Ordinary Shares Number: 241221.00
BCTX balance_sheet (quarterly, 2024-10-31) — Other Equity Adjustments: -138684.00
BCTX balance_sheet (quarterly, 2024-10-31) — Other Equity Interest: 13386453.00
BCTX income_statement (quarterly, 2024-10-31) — Other Gand A: 1487491.00
BCTX income_statement (quarterly, 2024-10-31) — Other Income Expense: -689494.00
BCTX balance_sheet (quarterly, 2024-10-31) — Payables: 4233968.00
BCTX balance_sheet (quarterly, 2024-10-31) — Payables And Accrued Expenses: 4988636.00
BCTX income_statement (quarterly, 2024-10-31) — Pretax Income: -5829276.00
BCTX cash_flow (quarterly, 2024-10-31) — Proceeds From Stock Option Exercised: 293251.00
BCTX cash_flow (quarterly, 2024-10-31) — Purchase Of Business: -75000.00
BCTX balance_sheet (quarterly, 2024-10-31) — Receivables: 2426830.00
BCTX income_statement (quarterly, 2024-10-31) — Reconciled Depreciation: 26657.00
BCTX income_statement (quarterly, 2024-10-31) — Research And Development: 3665341.00
BCTX balance_sheet (quarterly, 2024-10-31) — Retained Earnings: -91245872.00
BCTX income_statement (quarterly, 2024-10-31) — Selling General And Administration: 1487491.00
BCTX balance_sheet (quarterly, 2024-10-31) — Share Issued: 241221.00
BCTX cash_flow (quarterly, 2024-10-31) — Stock Based Compensation: 266971.00
BCTX balance_sheet (quarterly, 2024-10-31) — Stockholders Equity: 4042638.00
BCTX balance_sheet (quarterly, 2024-10-31) — Tangible Book Value: 3846660.00
BCTX income_statement (quarterly, 2024-10-31) — Tax Effect Of Unusual Items: 0.00
BCTX income_statement (quarterly, 2024-10-31) — Tax Rate For Calcs: 0.00
BCTX balance_sheet (quarterly, 2024-10-31) — Total Assets: 10414330.00
BCTX balance_sheet (quarterly, 2024-10-31) — Total Capitalization: 4042638.00
BCTX balance_sheet (quarterly, 2024-10-31) — Total Equity Gross Minority Interest: 3713015.00
BCTX income_statement (quarterly, 2024-10-31) — Total Expenses: 5152832.00
BCTX balance_sheet (quarterly, 2024-10-31) — Total Liabilities Net Minority Interest: 6701315.00
BCTX balance_sheet (quarterly, 2024-10-31) — Total Non Current Assets: 2195235.00
BCTX balance_sheet (quarterly, 2024-10-31) — Total Non Current Liabilities Net Minority Interest: 1712679.00
BCTX income_statement (quarterly, 2024-10-31) — Total Operating Income As Reported: -5152832.00
BCTX income_statement (quarterly, 2024-10-31) — Total Unusual Items: -617979.00
BCTX income_statement (quarterly, 2024-10-31) — Total Unusual Items Excluding Goodwill: -617979.00
BCTX balance_sheet (quarterly, 2024-10-31) — Working Capital: 3230459.00
BCTX income_statement (quarterly, 2025-01-31) — +Operating Expense: 7169443.00
BCTX income_statement (quarterly, 2025-01-31) — +Total Revenue: 0.00
BCTX balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 5003239.00
BCTX balance_sheet (quarterly, 2025-01-31) — Accounts Receivable: 2148919.00
BCTX cash_flow (quarterly, 2025-01-31) — Amortization Cash Flow: 3818.00
BCTX cash_flow (quarterly, 2025-01-31) — Amortization Of Intangibles: 3818.00
BCTX income_statement (quarterly, 2025-01-31) — Basic Average Shares: 269957.00
BCTX income_statement (quarterly, 2025-01-31) — Basic EPS: -23.31
BCTX cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 5792265.00
BCTX balance_sheet (quarterly, 2025-01-31) — Capital Stock: 85451119.00
BCTX balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 5013654.00
BCTX balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 5013654.00
BCTX cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: 5216611.00
BCTX cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: -75000.00
BCTX cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: -5920222.00
BCTX cash_flow (quarterly, 2025-01-31) — Change In Account Payable: 769271.00